z-logo
open-access-imgOpen Access
Immunotherapy in skin cancers - A narrative review
Author(s) -
V. T. Anjali,
Feroze Kaliyadan
Publication year - 2022
Publication title -
journal of skin and sexually transmitted diseases
Language(s) - English
Resource type - Journals
eISSN - 2994-6026
pISSN - 2582-3175
DOI - 10.25259/jsstd_74_2021
Subject(s) - immunotherapy , cancer immunotherapy , melanoma , medicine , cancer , immune system , context (archaeology) , skin cancer , narrative review , limiting , immunology , immunity , cancer research , biology , intensive care medicine , mechanical engineering , paleontology , engineering
Immunotherapy, in the context of cancers, involves the use of various drugs to stimulate the immune system to target cancer cells. Immunotherapy is being increasingly used for cutaneous malignancies, especially melanoma. Immunity plays an important part in protection against cancer. One of the factors limiting the effectiveness of host immunity is improper recognition of cancer cells. Sometimes, despite recognizing the cancer cells as abnormal, the immune response, for various reasons might not be strong enough to deal effectively with the cancer cells. Immunotherapy basically tries to address the two points mentioned above by improving the capacity of the immune system to recognize and effectively destroy cancer cells. In skin cancers, immunotherapy is best established for melanomas, but is increasingly being used for non-melanoma skin cancers too. This article reviews some of the general concepts about immunotherapy in cancer and discusses in detail, the available options and future possibilities in the applications of immunotherapy in skin cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom